The tweet was deleted by the author.
But we saved everything 🙂.
NVE has filed its Quarterly Report on Form 10-Q for the quarter ended 30 June with the U.S. Securities and Exchange Commission.
The filing provides detailed financial and operational information for the stated period. Investors and analysts are expected to review the document for further insights into the company performance.
NVE previously announced new research on noninvasive hemoglobin measurement using an NVE sensor, detailed in a study published in AIP Conference Proceedings. The company also introduced a noninvasive method for measuring hemoglobin with a proprietary sensor and Arduino, according to a company statement. These developments have focused on expanding NVE’s sensor applications in the medical field.